Maria Grazia Zizzo

Prof. Maria Grazia Zizzo

University of Palermo, Dept. Stebicef
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Pharmacological Research
Verified
Journal Article
Closed access
MAMichelangelo Auteri
Michelangelo Auteri
Maria Grazia ZizzoMaria Grazia Zizzo
Maria Grazia Zizzo
RSRosa Serio
Rosa Serio

1 May 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ECEmanuela F. Craparo
Emanuela F. Craparo
CSCarla Sardo
Carla Sardo
RSRosa Serio
Rosa Serio
Maria Grazia ZizzoMaria Grazia Zizzo
Maria Grazia Zizzo
MBMaria L. Bondì
Maria L. Bondì
Gennara CavallaroGennara Cavallaro
Gennara Cavallaro

16 January 2003 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RSRosa Serio
Rosa Serio
MAMassimiliano Alessandro
Massimiliano Alessandro
Maria Grazia ZizzoMaria Grazia Zizzo
Maria Grazia Zizzo
MTMaria Pia Tamburello
Maria Pia Tamburello
FMFlavia Mulè
Flavia Mulè

1 May 2010 in Pharmacological Research
Verified
Journal Article
Closed access
Maria Grazia ZizzoMaria Grazia Zizzo
Maria Grazia Zizzo
FMFlavia Mulè
Flavia Mulè
MMMariangela Mastropaolo
Mariangela Mastropaolo
RSRosa Serio
Rosa Serio

21 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
ACAdele CICIO
Adele CICIO
RSRosa Serio
Rosa Serio
Maria Grazia ZizzoMaria Grazia Zizzo
Maria Grazia Zizzo
Inflammatory bowel disease (IBD) is a group of intestinal disorders, of unknown etiology, characterized by chronic inflammation within the gut. They are gradually becoming critical because of the increasing incidence worldwide and improved diagnosis. Due to the important side effects observed during conventional therapy, natural bioactive components are now under intense investigation for the prevention and treatment of chronic illnesses. The Brassicaceae family comprises vegetables widely consumed all over the world. In recent decades, a growing body of literature has reported that extracts from the Brassicaceae family and their purified constituents have anti-inflammatory properties, which has generated interest from both the scientific community and clinicians. In this review, data from the literature are scrutinized and concisely presented demonstrating that Brassicaceae may have anti-IBD potential. The excellent biological activities of Brassicacea are widely attributable to their ability to regulate the levels of inflammatory and oxidant mediators, as well as their capacity for immunomodulatory regulation, maintenance of intestinal barrier integrity and intestinal flora balance. Possible future applications of bioactive-derived compounds from Brassicaceae for promoting intestinal health should be investigated.

15 June 2018 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
Maria Grazia ZizzoMaria Grazia Zizzo
Maria Grazia Zizzo
GCGaetano Felice Caldara
Gaetano Felice Caldara
ABAnnalisa Bellanca
Annalisa Bellanca
Domenico NuzzoDomenico Nuzzo
Domenico Nuzzo
MCMarta Di Carlo
Marta Di Carlo
RSRosa Serio
Rosa Serio